Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

TLX SP ?5.5 WT, SLActive? 10mm, RXD: medical device reports filed with FDA

602 reports name it, 2021–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

602
device reports naming the brand
0% of all MAUDE reports · about 123 a year
185
reports, 12 months to August 2026
145 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

602 medical device reports received by FDA name the brand "TLX SP ?5.5 WT, SLActive? 10mm, RXD" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from August 2021 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

185 reports arrived in the 12 months to August 2026, up 28% from 145 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (58%), loss of osseointegration (20.3%) and difficult to insert (1.3%). The patient problems coded most often are fibrosis, pain and hyperresponsive to stimuli. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01325Sep 2021: 0Oct 2021: 1Nov 2021: 3Dec 2021: 12022Jan 2022: 0Feb 2022: 1Mar 2022: 10Apr 2022: 1May 2022: 7Jun 2022: 2Jul 2022: 7Aug 2022: 4Sep 2022: 5Oct 2022: 7Nov 2022: 3Dec 2022: 62023Jan 2023: 3Feb 2023: 5Mar 2023: 4Apr 2023: 4May 2023: 16Jun 2023: 9Jul 2023: 10Aug 2023: 4Sep 2023: 13Oct 2023: 9Nov 2023: 10Dec 2023: 142024Jan 2024: 6Feb 2024: 16Mar 2024: 15Apr 2024: 18May 2024: 8Jun 2024: 12Jul 2024: 17Aug 2024: 18Sep 2024: 14Oct 2024: 11Nov 2024: 13Dec 2024: 182025Jan 2025: 9Feb 2025: 17Mar 2025: 10Apr 2025: 7May 2025: 0Jun 2025: 25Jul 2025: 5Aug 2025: 16Sep 2025: 18Oct 2025: 20Nov 2025: 16Dec 2025: 132026Jan 2026: 10Feb 2026: 9Mar 2026: 17Apr 2026: 15May 2026: 17Jun 2026: 18Jul 2026: 15Aug 2026: 17

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0831662021: 820212022: 5320222023: 10120232024: 16620242025: 15620252026: 1182026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%602
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report76.4%460
Voluntary report0%0
User facility report0%0
Distributor report23.6%142
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate34958%62.8%
Loss of osseointegration12220.3%22.4%
Difficult to insertthe device was hard to insert81.3%0.4%
Fracturea broken bone30.5%1.6%
Separation failure20.3%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis26343.7%
Painpain, site not specified11719.4%
Hyperresponsive to stimuli254.2%
Inflammationinflammation203.3%
Swelling/ edema183%
Hemorrhage/blood loss/bleeding132.2%
Abscessa collection of pus61%
Fistula40.7%
Hypersensitivity/allergic reaction40.7%
Numbnessnumbness40.7%
Sinus perforation40.7%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureTLX SP ?5.5 WT, SLActive? 10mm, RXDProduct code DZEAll MAUDE reports
Reports6023,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer76.4%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about TLX SP ?5.5 WT, SLActive? 10mm, RXD reports

How many FDA reports name TLX SP ?5.5 WT, SLActive? 10mm, RXD?

602 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 185 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (58%), loss of osseointegration (20.3%), difficult to insert (1.3%), fracture (0.5%) and separation failure (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (76.4%) and distributor reports (23.6%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that TLX SP ?5.5 WT, SLActive? 10mm, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.